Bristol Myers Squibb is a biopharmaceutical company that develops, manufactures, and markets prescription medicines for various diseases, including cancer, cardiovascular disease, and immunologic disorders. The company's key products include Opdivo, Revlimid, and Eliquis, which are used to treat a range of conditions, including lung cancer, multiple myeloma, and blood clots. As a leading player in the pharmaceutical industry, Bristol Myers Squibb plays a significant role in advancing medical research and improving patient outcomes.
S&P 500 closing prices, top movers, and sector performance — delivered daily.